Literature DB >> 21808282

Clinical diagnosis and staging of cholangiocarcinoma.

Boris Blechacz1, Mina Komuta, Tania Roskams, Gregory J Gores.   

Abstract

Cholangiocarcinoma is the most frequent biliary malignancy. It is difficult to diagnose owing to its anatomic location, growth patterns and lack of definite diagnostic criteria. Currently, cholangiocarcinoma is classified into the following types according to its anatomic location along the biliary tree: intrahepatic, perihilar or distal extrahepatic cholangiocarcinoma. These cholangiocarcinoma types differ in their biological behavior and management. The appropriate stratification of patients with regard to the anatomic location and stage of cholangiocarcinoma is a key determinate in their management. Staging systems can guide this stratification and provide prognostic information. In addition, staging systems are essential in order to compare and contrast the outcomes of different therapeutic approaches. A number of staging systems exist for cholangiocarcinoma-several early ones have been updated, and new ones are being developed. We discuss the emerging diagnostic criteria as well as the different staging systems for cholangiocarcinoma, and provide a critical appraisal regarding these advances in biliary tract malignancies.

Entities:  

Mesh:

Year:  2011        PMID: 21808282      PMCID: PMC3331791          DOI: 10.1038/nrgastro.2011.131

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  92 in total

1.  Perihilar cholangiocarcinoma: A much needed but imperfect new staging system.

Authors:  Masato Nagino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05       Impact factor: 46.802

2.  Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions.

Authors:  J E Lopera; J A Soto; F Múnera
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

3.  Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.

Authors:  A Rullier; B Le Bail; R Fawaz; J F Blanc; J Saric; P Bioulac-Sage
Journal:  Am J Surg Pathol       Date:  2000-06       Impact factor: 6.394

4.  Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach.

Authors:  Emmanuel E Zervos; Dana Osborne; Steven B Goldin; Desiree V Villadolid; Donald P Thometz; Alan Durkin; Larry C Carey; Alexander S Rosemurgy
Journal:  Am J Surg       Date:  2005-11       Impact factor: 2.565

5.  Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Authors:  Ramón Vilana; Alejandro Forner; Luis Bianchi; Angeles García-Criado; Jordi Rimola; Carlos Rodríguez de Lope; María Reig; Carmen Ayuso; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

Review 6.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

7.  Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.

Authors:  Takashi Kato; Eriko Tsukamoto; Yuji Kuge; Chietsugu Katoh; Toshikazu Nambu; Aichiro Nobuta; Satoshi Kondo; Masahiro Asaka; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-01       Impact factor: 9.236

8.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  Imaging of cholangiolocellular carcinoma of the liver.

Authors:  Yoshiki Asayama; Tsuyoshi Tajima; Daisuke Okamoto; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Daisuke Kakihara; Shinichi Aishima; Akinobu Taketomi; Hiroshi Honda
Journal:  Eur J Radiol       Date:  2009-09-24       Impact factor: 3.528

Review 10.  Fluorescence in situ hybridization in diagnostic cytology.

Authors:  Kevin C Halling; Benjamin R Kipp
Journal:  Hum Pathol       Date:  2007-08       Impact factor: 3.466

View more
  215 in total

1.  Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages.

Authors:  Guido Carpino; Vincenzo Cardinale; Paolo Onori; Antonio Franchitto; Pasquale Bartolomeo Berloco; Massimo Rossi; Yunfang Wang; Rossella Semeraro; Maurizio Anceschi; Roberto Brunelli; Domenico Alvaro; Lola M Reid; Eugenio Gaudio
Journal:  J Anat       Date:  2011-12-05       Impact factor: 2.610

Review 2.  Focal intrahepatic strictures: a review of diagnosis and management.

Authors:  David Yeo; Marcos Vinicius Perini; Vijayaragavan Muralidharan; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2012-07       Impact factor: 3.647

3.  Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance.

Authors:  Xiao-Ping Tan; Qing Zhang; Wei-Guo Dong; Xia-Wen Lei; Zi-Rong Yang
Journal:  Oncol Lett       Date:  2012-02-28       Impact factor: 2.967

4.  Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity.

Authors:  Vincenzo Cardinale; Guido Carpino; Lola Reid; Eugenio Gaudio; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

Review 5.  Staging of intrahepatic cholangiocarcinoma.

Authors:  Sean M Ronnekleiv-Kelly; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

6.  The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection.

Authors:  Akira Iwaku; Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Hirokazu Nishino; Masato Matsushima; Hisao Tajiri
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

Review 7.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

Review 8.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

9.  A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

Authors:  Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Hepat Oncol       Date:  2014-01-01

10.  Why does infection with some helminths cause cancer?

Authors:  Paul J Brindley; José M Correia da Costa; Banchob Sripa
Journal:  Trends Cancer       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.